Clinical Trials Browser

Phase 1/2 × Prostatic Neoplasms × talazoparib × Clear all

NCT04019327 2025-12-15

A Study of the Drugs Talazoparib and Temozolomide in Prostate Cancer

Phase 1/2 Completed

Prostatic Neoplasms